HomeNewsBusinessCompaniesNo immediate job cuts at GSKCH, but concerns remain after HUL buy

No immediate job cuts at GSKCH, but concerns remain after HUL buy

"These are complicated deals. They don't close overnight. We will not leave our people in the lurch as we have to run the business for next several quarters," said a person with knowledge of the matter

December 08, 2018 / 18:05 IST
Story continues below Advertisement
GSK Pharma | Company reported lower profit at Rs 76.5 crore in Q2FY21 compared to Rs 502.7 crore, revenue fell to Rs 879 crore from Rs 882 crore YoY.
GSK Pharma | Company reported lower profit at Rs 76.5 crore in Q2FY21 compared to Rs 502.7 crore, revenue fell to Rs 879 crore from Rs 882 crore YoY.

Viswanath Pilla & M Saraswathy Moneycontrol News

The fate of over 3,800 employees of GlaxoSmithKline Consumer Healthcare India (GSKCH) hangs in the balance after the company merged with Hindustan Unilever Limited (HUL) in deal valued at $3.8 billion early this week.

Moneycontrol learned from sources that there wouldn't be any rationalisation immediately at GSKCH as the deal may take at least four quarters to get all approvals.

Story continues below Advertisement

"These are complicated deals. They don't close overnight. We will not leave our people in the lurch, as we have to run the business for next several quarters," said a person with knowledge of the matter.

"When two companies come together, they will of course discuss about human resources, if you see the portfolio of HUL, they are not there in the healthcare drinks. And therefore they don't have the expertise. It's a complete virgin territory for them. For them to understand and have people expertise will be very critical. Am I saying that they will take all of us, the answer is no," said the person quoted above.